Literature DB >> 25535225

Fatal lymphomatoid granulomatosis with primary CNS-involvement in an immunocompetent 80-year-old woman.

David G Olmes1, Abbas Agaimy2, Stephan Kloska3, Ralf A Linker1.   

Abstract

An 80-year-old woman presented with weight loss, fatigue, dizziness and a brain stem lesion. Extensive work-up revealed lymphomatoid granulomatosis (LYG) with primary clinical manifestation in the central nervous system (CNS), a rare Epstein-Barr virus-driven multisystem lymphoproliferative disorder, to be causative for the symptoms. Immunochemotherapy consisting of rituximab and temozolomide was started, but the disease progressed and the patient subsequently died. Histology, diagnostic criteria, differential diagnosis and treatment options for LYG with CNS involvement are discussed. This case demonstrates that LYG with CNS involvement may necessitate more aggressive treatment approaches than combination therapy with rituximab and temozolomide. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25535225      PMCID: PMC4275695          DOI: 10.1136/bcr-2014-206825

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

Review 1.  Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.

Authors:  Roelien H Enting; Alexis Demopoulos; Lisa M DeAngelis; Lauren E Abrey
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

Review 2.  Current histological diagnosis of lymphomatoid granulomatosis.

Authors:  Thomas V Colby
Journal:  Mod Pathol       Date:  2012-01       Impact factor: 7.842

3.  Teaching NeuroImages: lymphomatoid granulomatosis involving lung and brain in an immunocompetent woman.

Authors:  J Yang; S Shin; M Fowkes; S Krieger; J A Strauchen; M Smethurst; A Demopoulos
Journal:  Neurology       Date:  2011-09-27       Impact factor: 9.910

Review 4.  Spectrum of Epstein-Barr virus-related diseases: a pictorial review.

Authors:  Eriko Maeda; Masaaki Akahane; Shigeru Kiryu; Nobuyuki Kato; Takeharu Yoshikawa; Naoto Hayashi; Shigeki Aoki; Manabu Minami; Hiroshi Uozaki; Masashi Fukayama; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2009-02-08       Impact factor: 2.374

5.  Lymphomatoid granulomatosis.

Authors:  A A Liebow; C R Carrington; P J Friedman
Journal:  Hum Pathol       Date:  1972-12       Impact factor: 3.466

6.  CNS lymphomatoid granulomatosis in AIDS: CT and MR appearances.

Authors:  J C George; K S Caldemeyer; R R Smith; J T Czaja
Journal:  AJR Am J Roentgenol       Date:  1993-08       Impact factor: 3.959

7.  Rituximab in lymphomatoid granulomatosis.

Authors:  Carmen Hernández-Marqués; Alvaro Lassaletta; Antonio Torrelo; Miguel Ángel López-Pino; Javier Álvarez-Coca; Inmaculada De Prada; Ángela Hernández-Martín; Luis Madero
Journal:  J Pediatr Hematol Oncol       Date:  2014-03       Impact factor: 1.289

8.  Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.

Authors:  Eric T Wong; Roy Tishler; Loretta Barron; Julian K Wu
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

9.  Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids.

Authors:  Hjalmar J De Graaff; Mike P Wattjes; Annemieke J Rozemuller-Kwakkel; Axel Petzold; Joep Killestein
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

10.  Lymphomatoid granulomatosis treated successfully with rituximab in a renal transplant patient.

Authors:  Cindy Castrale; Wael El Haggan; Françoise Chapon; Oumedaly Reman; Thierry Lobbedez; Jean Philippe Ryckelynck; Bruno Hurault de Ligny
Journal:  J Transplant       Date:  2011-04-19
View more
  4 in total

1.  Use of rituximab in lymphomatoid granulomatosis with isolated central nervous system involvement.

Authors:  Jesse Mooneyham; Cesar Gentille; Andrea Barbieri; Shilpan Shah
Journal:  BMJ Case Rep       Date:  2020-09-07

2.  B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma.

Authors:  Rodrigo Javier; Nawal Shaikh; Maciej S Lesniak; Adam Sonabend; Roger Stupp; Amir Behdad; Craig Horbinski
Journal:  Diagn Pathol       Date:  2018-06-05       Impact factor: 2.644

Review 3.  Approach to Peribronchovascular Disease on CT.

Authors:  Jane P Ko; Francis Girvin; William Moore; David P Naidich
Journal:  Semin Ultrasound CT MR       Date:  2018-12-20       Impact factor: 1.875

4.  High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy.

Authors:  Sakiko Harada; Jun Ando; Miki Ando; Hideaki Nitta; Tadaaki Inano; Yusuke Hirasawa; Yoshiki Furukawa; Shintaro Kinoshita; Akihide Kondo; Koichi Ohshima; Norio Komatsu
Journal:  Intern Med       Date:  2021-06-12       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.